VivaCell Biotechnology España
1 clinical trials · Sponsor
◉ Watch VivaCell Biotechnology España
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease (NCT06774040) | VivaCell Biotechnology España | 2026-01-01 |
Track VivaCell Biotechnology España automatically
Every clearance here is in the API, with alerts when new ones post.